First Female CEO for 107-Year-Old Cancer Organization
Oncology researcher and administrator Karen Knudsen, MBA, PhD will be the next chief executive officer of the American Cancer Society …
Home »
Novel Radiopharmaceutical Beats Cabazitaxel in mCRPC
A novel radiopharmaceutical was more active than cabazitaxel against metastatic castration-resistant prostate cancer (mCRPC) and caused fewer grade 3/4 adverse …
Prostate cancer symptoms: The ‘difficulty’ when going to the toilet to watch out for
Prostate cancer starts in the prostate gland, which is found at the base of the bladder and is about the …
Prostate cancer: How new immunotherapy can help men with ‘very poor’ prognosis
Prostate cancer is one of the most common forms of cancer in the world, affecting approximately 1,276,106 men in 2018. …
Nanoparticles’ movements reveal whether they can successfully target cancer: Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can …
Study links progenitor cells to age-related prostate growth: As the organ enlarges, the risk for cancer and other diseases increases
The prostates of older mice contain more luminal progenitor cells — cells capable of generating new prostate tissue — than …
Study confirms disparities in triple-negative breast cancer diagnoses
Women of color and young women may face elevated risks of developing triple-negative breast cancers, a type of cancer that …
Discovery of mechanism behind precision cancer drug opens door for more targeted treatment: Research explains how the drugs work, who else might benefit from their use
New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted …
New study challenges claim that exogenous RNA is essential for sperm function
Scientists from the University of Bath are challenging the claims of two high profile papers from 2018 which reported that …
New way to make cancer self-destruct: Penn study finds blocking the ATF4 gene causes tumors to die from too much stress
For years, researchers have been trying to target a gene called MYC that is known to drive tumor growth in …
Researchers discriminate between mutations that promote cancer growth and those that don’t
Until now, researchers believed recurrent mutations (hotspot mutations) in cancer tumors were the important mutations (driver mutations) that promoted cancer …
Potential breakthrough in understanding tumor dormancy
Scientists at VCU Massey Cancer Center may have uncovered a primary method through which cancer cells exist undetected in an …
A new approach to targeting cancer cells
A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents …
Prostate cancer warning – three common symptoms when you go to the toilet
Prostate cancer is the most common type of cancer to be diagnosed in men, in the UK. The diseases affects the …
Drug takes aim at cancer metastasis
Many cancers are relatively harmless at their site of origin, and it is only when they metastasize to sites like …
Ovary function is preserved in transgender men at one year of testosterone therapy
Transgender men preserve their fertility potential even after one year of treatment with the male hormone testosterone, according to a …
Robots can detect breast cancer as well as radiologists
A new paper in the Journal of the National Cancer Institute suggests that artificial intelligence systems may be able to …
Penis development needs more than just testes and testosterone: ‘Backdoor’ pathway to masculinity involves androsterone from multiple tissues, including the placenta
Proper development of the fetal penis requires not just testosterone from the testes, but a second hormone produced by other …